HIV and AIDS in adolescents

Adolescent Medicine Clinics

Volumn 15, Issue 2, 2004, Pages 369-391

  Futterman, Donna C ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ASTEMIZOLE; AZITHROMYCIN; CD4 ANTIGEN; CHICKENPOX VACCINE; CLARITHROMYCIN; DIPHTHERIA VACCINE; EFAVIRENZ; GESTAGEN; HEPATITIS B VACCINE; INDINAVIR; INFLUENZA VACCINE; LOPINAVIR; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; MEDROXYPROGESTERONE ACETATE; METHADONE; METRONIDAZOLE; MIDAZOLAM; NEVIRAPINE; NUCLEOSIDE DERIVATIVE; ORAL CONTRACEPTIVE AGENT; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TETANUS TOXOID; TRIAZOLAM; UNINDEXED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENCE; CELL COUNT; CULTURAL ANTHROPOLOGY; DEATH; DISEASE COURSE; DISEASE TRANSMISSION; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG FATALITY; DRUG INDICATION; DYING; ENZYME ACTIVITY; EPIDEMIOLOGICAL DATA; FAMILY; HEALTH CARE NEED; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SERVICE; HEALTH STATUS; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; JUVENILE; LABORATORY TEST; LEGAL ASPECT; MENTAL DISEASE; PARENT; PATIENT COMPLIANCE; PATIENT COUNSELING; PHYSICAL EXAMINATION; PREVALENCE; PRIMARY MEDICAL CARE; PROPHYLAXIS; PROTEIN BINDING; REVACCINATION; REVIEW; SCREENING; SEROLOGY; SEXUAL BEHAVIOR; SEXUAL DEVELOPMENT; SEXUALITY; SEXUALLY TRANSMITTED DISEASE; SOCIAL PSYCHOLOGY; SOCIOECONOMICS; SUBSTANCE ABUSE; SYMPTOMATOLOGY; TOXICITY; VIRUS LOAD;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; AIDS SERODIAGNOSIS; AIDS VACCINES; ANTI-HIV AGENTS; COUNSELING; FEMALE; HIV INFECTIONS; HUMANS; MALE; PATIENT COMPLIANCE; RISK FACTORS; UNITED STATES;

EID: 3142534451     PISSN: 15473368     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.admecli.2004.02.009     Document Type: Review

References (65)

1. UNAIDS/World Health Organization Report on the Global Epidemic. 2002;UNAIDS/World Health Organization, Geneva (Switzerland)
2. Centers for Disease Control and Prevention. HIV/AIDS surveillance report 2001;13(2):1-56
3. Centers for Disease Control and Prevention HIV incidence among young men who have sex with men - seven US cities, 1994-2000. MMWR Morb Mortal Wkly Rep. 50(21):2001;440-444
4. Centers for Disease Control and Prevention Unrecognized HIV infection, risk behaviors, and perceptions of risk among young black men who have sex with men - six US cities, 1994-1998. MMWR. 51(33):2002;733-736
5. Institute of Medicine The hidden epidemic: confronting sexually transmitted diseases. 1997;National Academy Press, Washington (DC)
6. Centers for Disease Control and Prevention Tracking hidden epidemics. Trends in STDs in the United States, 2000. 2001;US Department of Health and Human Services, Atlanta (GA)
7. Centers for Disease Control and Prevention Sexually transmitted disease surveillance, 2001. 2002;US Department of Health and Human Services, Atlanta, (GA)
8. Singh S., Wulf D., Samara R., Cuca Y.P. Gender differences in the timing of first intercourse: data from 14 countries. Int Fam Plan Perspect 2000;(1):21-8, 43
9. Grunbaum J.A., Kann L., Kinchen S.A., Williams B., Ross J.G., Lowry R., et al. Youth risk behavior surveillance -United States, 2001. MMWR Surveill Summ. 51(4):2002;1-62
10. D'Angelo L.J., Getson P.R., Luban N.L., Gayle H.D. Human immunodeficiency virus infection in urban adolescents: can we predict who is at risk? Pediatrics. 88(5):1991;982-986
11. Rotheram-Borus M., Koopman C., Ehrhardt A.A. Homeless youth and HIV infection. Am Psychol. 46(11):1991;1188-1197
12. Morris R., Baker C., Huscroft S. Incarcerated youth at risk for HIV infection. DiClemente R.J. Adolescents and AIDS: a generation in jeopardy. 1992;52-70 Sage, Newbury Park (CA)
13. Katz M.H., McFarland W., Guillin V., Fenstersheib M., Shaw M., Kellogg T., et al. Continuing high prevalence of HIV and risk behaviors among young men who have sex with men: the Young Men's Survey in the San Francisco Bay Area in 1992 to 1993 and in 1994 to 1995. J Acquir Immune Defic Syndr Hum Retrovirol. 19(2):1998;178-181
14. Ryan C., Futterman D. Lesbian and gay youth: care and counseling. 1998;Columbia University Press, New York
15. Wilson C.M., Houser J., Partlow C., Rudy B.J., Futterman D.C., Friedman L.B. The REACH (Reaching for Excellence in Adolescent Care and Health) Project: study design, methods, and population profile. J Adolesc Health. 29(3 Suppl):2001;8-18
16. Murphy D.A., Durako S.J., Moscicki A.B., Vermund S.H., Ma Y., Schwarz D.F., et al. No change in health-risk behavior over time among HIV-infected adolescents in care: role of psychological distress. J Adolesc Health. 29(3S):2001;57-63
17. Centers for Disease Control and Prevention HIV/STD risks in young men who have sex with men who do not disclose their sexual orientation - six US cities, 1994-2000. MMWR Morb Mortal Wkly Rep. 52(5):2003;81-86
18. Chabon B., Futterman D., Hoffman N.D. HIV infection in parents of youths with behaviorally acquired HIV. Am J Public Health. 91(4):2001;649-650
19. Moscicki A.B., Ellenberg J.H., Vermund S.H., Holland C.A., Darragh T., Crowley-Nowick P.A., et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med. 154(2):2000;127-134
20. Futterman D., Hein K., Reuben N., Dell R., Shaffer N. Human immunodeficiency virus-infected adolescents: the first 50 patients in a New York City program. Pediatrics. 91(4):1993;730-735
21. Rogers A.S., Futterman D., Levin L., D'Angelo L. A profile of human immunodeficiency virus-infected adolescents receiving health care services at selected sites in the United States. J Adolesc Health. 19(6):1996;401-408
22. Futterman D., Rogers A., D'Angelo L., et al. Transmission dynamics and clinical status of youth. J Adolesc Health. 16:1995;134
23. Dryfoos J.G. Adolescents at risk: prevalence and prevention. 1990;Oxford University Press, New York
24. Grubman S., Gross E., Lerner-Weiss N., Hernandez M., McSherry G.D., et al. Older children and adolescents living with perinatally acquired human immunodeficiency virus infection. Pediatrics. 95(5):1995;657-663
25. Gortmaker S.L., Hughes M., Cervia J., Brady M., Johnson G.M., Seage G.R. III, et al. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med. 345(21):2001;1522-1528
26. Committee on Pediatrics AIDS American Academy of Pediatrics Disclosure of illness status to children and adolescents with HIV infection. Pediatrics. 103(1):1999;164-166
27. Resnick M., Blum R.W., Hedin D. The appropriateness of health services for adolescents: youth's opinions and attitudes. J Adolesc Health Care. 1(2):1980;137-141
28. Kunins H., Hein K., Futterman D., Tapley E., Elliot A.S. Guide to adolescent HIV/AIDS program development. J Adolesc Health. 14(Suppl 5):1993;1S-140S
29. English A. Expanding access to HIV services for adolescents: legal and ethical issues in adolescents and AIDS. DiClemente R. A generation in jeopardy. 1992;262-283 Sage Publications, New York
30. Cheng T.L., Savageau J.A., Sattler A.L., DeWitt T.G. Confidentiality in health care. A survey of knowledge, perceptions, and attitudes among high school students. JAMA. 269(11):1993;1404-1407
31. Wilson C.M., Ellenberg J.H., Sawyer M.K., Belzer M., Crowley-Nowick P.A., Puga A., et al. Serologic response to hepatitis B vaccine in HIV infected and high-risk HIV uninfected adolescents in the REACH cohort. Reaching for Excellence in Adolescent Care and Health. J Adolesc Health. 29(Suppl 3):2001;123-129
32. Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines 2002. MMWR Recomm Rep. 10;51(RR-6):2002;1-78
33. Hoffman N.D., Kelly C., Futterman D. Tuberculosis infection in human immunodeficiency virus-positive adolescents and young adults: a New York City cohort. Pediatrics. 97(2):1996;198-203
34. D'Angelo L.J., Getson P.R., Luban N.L., Gayle H.D. Human immunodeficiency virus infection in urban adolescents: can we predict who is at risk? Pediatrics. 88(5):1991;982-986
35. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children Guidelines for the use of antiretroviral agents in pediatric HIV infection. 2003;Department of Health and Human Services, Atlanta (GA)
36. Panel on Clinical Practices for Treatment of HIV Infection Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. 2003;Department of Health and Human Services, Atlanta (GA)
37. USPHS/IDSA Prevention of Opportunistic Infections Working Group 2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. 2001;Department of Health and Human Services, Atlanta (GA)
38. Pham T., Belzer M., Church J.A., Kitchen C., Wilson C.M., Douglas S.D., et al. Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles. Clin Diagn Lab Immunol. 10(2):2003;323-328
39. Murphy D.A., Sarr M., Durako S.J., Moscicki A.B., Wilson C.M., Muenz L.R. Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med. 157(3):2003;249-255
40. Murphy D.A., Wilson C.M., Durako S.J., Muenz L.R., Belzer M. Adolescent Medicine HIV/AIDS Research Network. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA. AIDS Care. 13(1):2001;27-40
41. Rogers A.S., Miller S., Murphy D.A., Tanney M., Fortune T., and the TREAT Project Team. The TREAT project (Therapeutic Regimens Enhancing Adherence in Teens): theory and preliminary results. J Adolesc Health 2001;29(3S):30-8
42. Gulick R.M., Ribaudo H.J., Shikuma C.M., et al. ACTG 5095: a comparative study of 3 protease inhibitor-sparing antiretroviral regimens for the initial treatment of HIV infection [abstract 41]. Program and abstracts of the 2nd IAS Conference on HIV Pathogenesis and Treatment. Antiviral Therapy. 8(Suppl 1):2003;S194-S195
43. Henderson R., Colgrove J., Lusk H. A survey of the mental health care needs of HIV+ adolescents and young adults [abstract 24230]. Program and abstracts of the 12th World AIDS Conference, Geneva; 1998:1998;485 International AIDS Society, Geneva, Switzerland
44. Blum R.W., Garell D., Hodgman C.H., Jorissen T.W., Okinow N.A., Orr D.P., et al. Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. J Adolesc Health. 14(7):1993;570-576
45. Johnson C.P. Transition into adulthood. Pediatr Ann. 24(5):1995;268-273
46. Telfair J., Myers J., Drezner S. Transfer as a component of the transition of adolescents with sickle cell disease to adult care: adolescent, adult, and parent perspectives. J Adolesc Health. 15(7):1994;558-565
47. American Academy of Pediatrics American Academy of Family Physicians American College of Physicians-American Society of Internal Medicine A consensus statement on health care transitions for young adults with special health care needs. Pediatrics. 110(6 Pt 2):2002;1304-1306
48. Rawitscher L.A., Saitz R., Friedman L.S. Adolescents' preferences regarding human immunodeficiency virus (HIV)-related physician counseling and HIV testing. Pediatrics. 96(1 Pt 1):1995;52-58
49. Goodman E., Tipton A.C., Hecht L., Chesney M.A. Perseverance pays off: health care providers' impact on HIV testing decisions by adolescent females. Pediatrics. 94(6 Pt 1):1994;878-882
50. Chabon B., Futterman D., Jones C. Adolescent HIV Counseling and Testing Protocol. Ryan C., Futterman D. Lesbian and gay youth: care and counseling. 1998;Columbia University Press, New York
51. Technical Expert Panel Review of CDC HIV Counseling, Testing, and Referral Guidelines Revised guidelines for HIV counseling, testing, and referral. MMWR. 50(RR19):2001;1-58
52. Futterman D., Stafford S.R., Madhava V. To test or not to test is no longer a question: time to ACTS (assess, consent, test, support).a rapid new paradigm [abstract M2-C0803]. Proceedings and abstracts of the 2003 National HIV Prevention Conference, Atlanta, 2003:1998;Centers for Disease Control and Prevention, Atlanta, (GA)
53. Catania J.A., Kegeles S.M., Coates T.J. Towards an understanding of risk behavior: an AIDS risk reduction model (ARRM). Health Educ Q. 17(1):1990;53-72
54. Rotheram-Borus M.J., Miller S. Secondary prevention for youths living with HIV. AIDS Care. 10(1):1998;17-34
55. Kirby D., Short L., Collins J., Rugg D., Kolbe L., Howard M., et al. School-based programs to reduce sexual risk behaviors: a review of effectiveness. Public Health Rep. 109(3):1994;339-360
56. Kirby B.D. Understanding what works and what doesn't in reducing adolescent sexual risk-taking. Fam Plan Perspect. 33(6):2001;276-281
57. Resnick M.D., Bearman P.S., Blum R.W., Bauman K.E., Harris K.M., Jones J., et al. Protecting adolescents from harm. Findings from the National Longitudinal Study on Adolescent Health. JAMA. 278(10):1997;823-832
58. Miller K.S., Levin M.L., Whitaker D.J., Xu X. Patterns of condom use among adolescents: the impact of mother-adolescent communication. Am J Public Health. 88(10):1998;1542-1544
59. Futterman D.C., Stafford S.R., Marrero L., Tobkes C., Harriet-Jackson P. Hittin' the zips: utilizing social marketing and targeted community based HIV testing to improve HIV case finding and prevention in HIV vulnerable neighborhoods [abstract T1-C2004]. Proceedings and abstracts of the 2003 National HIV Prevention Conference, Atlanta, 2003:2003;Centers for Disease Control and Prevention, Atlanta (GA)
60. Futterman D.C., Rudy B.J., Peralta L., Wolfson S., Guttmacher S., Rogers A.S., and the ACCESS Project Team. The ACCESS project (adolescents connected to counseling, evaluation, and special services): social marketing to promote HIV testing to adolescents, method and first year results from a six city campaign. J Adolesc Health 2001;29(3S):19-29
61. Kaur A., Johnson R.P. HIV pathogenesis and vaccine development. Top HIV Med. 11(3):2003;76-85
62. McMichael A.J., Hanke T. HIV vaccines 1983-2003. Nat Med. 9(7):2003;874-880
63. Rudy B.J., Crowley-Nowick P.A., Douglas S.D. Immunology and the REACH study: HIV immunology and preliminary findings. Reaching for Excellence in Adolescent Care and Health. J Adolesc Health. 29(Suppl 3):2001;39-48
64. Shrier L.A., Bowman F.P., Lin M., Crowley-Nowick P.A. Mucosal immunity of the adolescent female genital tract. J Adolesc Health. 32(3):2003;183-186
65. Centers for Disease Control and Prevention Recommended adult immunization schedule - United States, 2002-2003. MMWR Morb Mortal Wkly Rep. 51(40):2002;904-908